IGF2BP3 and urinary bladder carcinoma: In bladder cancer, expression of IGF2BP3 was significantly upregulated in tumors compared to normal tissues, with a median level of 1.007 in tumor and 0.170 in normal tissue (p < 0.001) (Fig. 2).